PF-367 |
PF-367 : Inhibitor of GSK3A, GSK3B
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| GSK3A |
| |
| GSK3B |
|
|
Inhibitor
up to 5 uM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
PF-367 was screened against a broad panel of 240 kinases in biochemical functional assays at a conce ...
Potency Cellular
In Vitro
GSK3A
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1002/anie.201603797
GSK3B
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1002/anie.201603797
In Vivo Validations
Rat
Dose: 50 mg/Kg
Route of delivery:
Intravenous
Target engagement assay:
PF-367 showed a rapid 76 % reduction of P-tau levels in the brain and 92 % reduction of phospho-glycogen synthase (pGS) in skeletal muscle after one hour of administration in rats
DOI Reference: 10.1002/anie.201603797
Chemical Information
| Molecular Formula | C16H16ClN5O3 |
| SMILEs | COc1ccc(-c2ocnc2C(=O)NCCCn2cncn2)cc1Cl |
| InChI | InChI=1S/C16H16ClN5O3/c1-24-13-4-3-11(7-12(13)17)15-14(20-10-25-15)16(23)19-5-2-6-22-9-18-8-21-22/h3-4,7-10H,2,5-6H2,1H3,(H,19,23) |
| Molecular weight | 361.09 Da |
| AlogP | 2.4152000000000005 |
| HBond acceptors | 8 |
| HBond donors | 1 |
| Atoms | 41 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.